Have a personal or library account? Click to login
Outcomes of hepatic resection for hepatocellular carcinoma with major portal or hepatic vein tumor thrombosis: retrospective cohort study Cover

Outcomes of hepatic resection for hepatocellular carcinoma with major portal or hepatic vein tumor thrombosis: retrospective cohort study

Open Access
|Mar 2017

Figures & Tables

Figure 1

Recurrence-free survival after hepatic resection with tumor thrombectomy
Recurrence-free survival after hepatic resection with tumor thrombectomy

Figure 2

Recurrence-free survival after hepatic resection with tumor thrombectomy
Recurrence-free survival after hepatic resection with tumor thrombectomy

Perioperative outcomes

n (%) or mean (standard deviation)
Operative procedure
 Posterior sectionectomy2 (15)
 Right/left hepatectomy10 (77)
 Right trisectionectomy1 (8)
Operative time (min)323 (122.9)
Estimated blood loss (mL)1439 (1372.7)
Length of stay (days)14 (5.7)
Complications
 Wound infection2
 Pleural effusion5
 Intraabdominal collection1
 Bile leakage1
Pathological results
Resection margins
 R0 (free margins)10 (77)
 R1 (microscopically positive)3 (23)
Tumor differentiation
 Moderate5 (39)
 Poor8 (62)
Satellite nodule positive3 (23)

Patient and tumor characteristics

Characteristicn (%) or mean (standard deviation)
Age (years)51.4 (9.5)
Male sex12 (92)
Underlying liver disease
 Hepatitis B virus (HBV)7 (54)
 HBV and hepatitis C virus (HCV) HBV2 (15)
and hepatitis C infection (HCV)4 (31)
 Non-HBV/HCV
 Tumor diameter (cm)11.2 (5.9)
 Child–Pugh A13 (100)
 α-Fetoprotein at diagnosis (IU/mL)13615 (41129)
Tumor thrombus location
 2nd branch portal vein (PV)3 (23)
 1st branch PV (right or left PV)4 (31)
 Main PV3 (23)
 Hepatic vein/inferior vena cava3 (23)

Univariate Cox proportional hazards model analysis to identify prognostic factors related to recurrence free and overall survival

Recurrence free survival HR (95% CI), POverall survival HR (95% CI), PPrognostic factor
0.81 (0.20 to 3.25), 0.760.70 (0.09 to 5.09), 0.72Tumor size ≥10 cm
2.07 (0.41 to 10.45), 0.373.54 (0.50 to 25.28), 0.21R0, tumor free resection margin
2.80 (0.56 to 14.02), 0.18

P, no death of patients without cirrhosis during follow up

0.056
Liver cirrhosis
3.62 (0.44 to 30.04), 0.20

P, no death of patients without preoperative transarterial chemoembolization during follow up

0.24
Preop transarterial chemoembolization
DOI: https://doi.org/10.5372/1905-7415.1005.511 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 477 - 482
Published on: Mar 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Wipusit Taesombat, Boonchoo Sirichindakul, Bunthoon Nonthasoot, Jade Suphapol, Methee Sutherasan, Supanit Nivatvongs, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.